What does recovery really look like after aggressive peritoneal cancer surgery?
NCT ID NCT03503071
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This study follows people with colorectal cancer that has spread to the lining of the abdomen (peritoneal metastasis) or with pseudomyxoma peritonei, a rare tumor of the abdominal cavity. Participants undergo cytoreductive surgery to remove all visible tumors, followed by intraperitoneal chemotherapy delivered directly into the abdomen. The goal is to measure how pain and overall quality of life change during the recovery period, using standard questionnaires. The findings could help set realistic expectations and improve support for patients facing this demanding treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cytoreductive surgery combined with intraperitoneal chemotherapy (either early postoperative or hyperthermic)
- What this could lead to
- If successful, this could help doctors better prepare patients for the recovery journey after this intensive treatment, improving supportive care and quality of life.
- What could go wrong
- This is an observational study, so it won't test a new treatment. The results may not apply to all patients, and recovery experiences can vary widely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kyungpook National University Chilgok Hospital
Daegu, 41404, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a vaccine boost immunotherapy against a stubborn cancer?
- Chemo holidays put to the test: can scheduled breaks beat continuous treatment for advanced colorectal cancer?
- Can two immune boosters outsmart Chemo-Resistant colon cancer?
- Could a liver transplant from a living donor help fight colorectal cancer that spread?
- Experimental drug SHR-A1904 takes on Hard-to-Treat colorectal cancer